[Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors]

Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trial.

ESMO gastrointestinal oncology·2026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer.

ESMO open·2025

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Annales de dermatologie et de venereologie·2025

Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study.

ESMO open·2025

13-year survival oligometastatic Merkel cell carcinoma: a case report.

Journal of medical case reports·2024

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials].

Bulletin du cancer·2026

[Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)].

Bulletin du cancer·2026

[Telemonitoring in Oncology: A French overview between 2022 and 2025].

Bulletin du cancer·2026

[Antibiotic use following pediatric hematopoietic stem cell transplantation (SFGM-TC)].

Bulletin du cancer·2026

[Facing a patient's wish to hasten death in palliative care: Professionals' experiences, practices, and interactional adjustments].

Bulletin du cancer·2026

[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].

Bulletin du cancer·2026

Natural Products as Anti-Angiogenic Agents: Molecular Targets, Signaling Pathways, and Mechanistic Insights.

Current pharmaceutical design·2026

Outcomes of Percutaneous Transhepatic Biliary Drainage in Patients With Malignant Biliary Obstruction Receiving Palliative Care.

The American journal of hospice & palliative care·2026

Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review).

International journal of oncology·2026

Anti-RANKL antibody treatment mitigates subchondral bone loss and cartilage degeneration without affecting synovial inflammation in a mouse model of rotator cuff tear arthropathy.

Bone & joint research·2026

Spontaneous Tumor Lysis Syndrome in Refractory Metastatic Esophageal Adenocarcinoma Presenting With Septic Shock.

Cureus·2026

Chitosan-Coated Oleuropein Nanoliposomes Enable Dose-Sparing Suppression of Serum Inflammatory Markers in a TNF-α-Induced Vascular Inflammation Model.

ACS omega·2026

Related Experiment Videos

[Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth

Related Concept Videos

Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trial.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer.

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study.

13-year survival oligometastatic Merkel cell carcinoma: a case report.

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

[Effects of phytoestrogens on prognosis and hormonal markers of breast cancer: A systematic review of randomized controlled trials].

[Indications for chimerism analysis on sorted cell populations after allogeneic hematopoietic stem cell transplantation (SFGM-TC)].

[Telemonitoring in Oncology: A French overview between 2022 and 2025].

[Antibiotic use following pediatric hematopoietic stem cell transplantation (SFGM-TC)].

[Facing a patient's wish to hasten death in palliative care: Professionals' experiences, practices, and interactional adjustments].

[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].

Natural Products as Anti-Angiogenic Agents: Molecular Targets, Signaling Pathways, and Mechanistic Insights.

Outcomes of Percutaneous Transhepatic Biliary Drainage in Patients With Malignant Biliary Obstruction Receiving Palliative Care.

Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review).

Anti-RANKL antibody treatment mitigates subchondral bone loss and cartilage degeneration without affecting synovial inflammation in a mouse model of rotator cuff tear arthropathy.

Spontaneous Tumor Lysis Syndrome in Refractory Metastatic Esophageal Adenocarcinoma Presenting With Septic Shock.

Chitosan-Coated Oleuropein Nanoliposomes Enable Dose-Sparing Suppression of Serum Inflammatory Markers in a TNF-α-Induced Vascular Inflammation Model.

Related Experiment Videos

[Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth...

Related Concept Videos

Related Articles

[Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth